Healthy volunteers help test injection devices for new drug
NCT ID NCT06908577
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether the drug tozorakimab enters the body the same way when given by two different injection devices: an autoinjector and a prefilled syringe. 254 healthy adults each received one injection. The goal was to see if the devices deliver the drug consistently, which helps with future use. No treatment was given for any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Glendale, California, 91206, United States
-
Research Site
Baltimore, Maryland, 21225, United States
-
Research Site
Berlin, 14050, Germany
-
Research Site
Harrow, HA1 3UJ, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Mind over movement: can imagining exercise boost balance and brainpower?
- Can a cancer drug be tailored for japanese patients? a new trial seeks answers
- Which pill works best? a trial puts elecoglipron formulations to the test
- Vitamin c may shield postmenopausal hearts without hormones
- Inhaled experimental drug targets tough lung infections
- Meal timing and stomach acid drugs may change how this experimental drug works